Pharmacopeia, Inc.

74 articles about Pharmacopeia, Inc.

• Ligand Pharmaceuticals Inc. Completes Pharmacopeia, Inc. Acquisition

  12/29/2008

• Quantros Acquires MEDMARX(R) from United States Pharmacopeia, Inc.

  12/9/2008

• Pharmacopeia, Inc. to Request a Hearing With NASDAQ Following Receipt of Notice of Non-Compliance

  11/10/2008

• Pharmacopeia, Inc. Announces Third Quarter 2008 Financial Results

  11/7/2008

• Ligand Pharmaceuticals Inc. and Pharmacopeia, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

  11/4/2008

• Ligand Pharmaceuticals Inc. and Pharmacopeia, Inc. to Present At the Oppenheimer 19th Annual Healthcare Conference

  10/29/2008

• Pharmacopeia, Inc. Receives Notification From NASDAQ

  10/3/2008

• Ligand Pharmaceuticals Inc. to Acquire Pharmacopeia, Inc. for Stock and Contingent Value Rights for $70M

  9/25/2008

• Pharmacopeia, Inc. and GlaxoSmithKline Collaboration Identifies Sixth Lead Compound

  9/16/2008

• Pharmacopeia, Inc. to Present At the Canaccord Adams 28th Annual Global Growth Conference

  7/30/2008

• Pharmacopeia, Inc. Advances Therapeutic Program With GlaxoSmithKline

  7/24/2008

• Pharmacopeia, Inc. to Present At the BMO Capital Markets 8th Annual Focus On Healthcare Conference

  7/23/2008

• Pharmacopeia, Inc. to Host Second Quarter 2008 Financial Results Webcast and Conference Call

  7/17/2008

• Pharmacopeia, Inc. Receives Milestone Payment from GlaxoSmithKline as a Result of Lead Compound Identification

  6/4/2008

• Pharmacopeia, Inc. and GlaxoSmithKline Collaboration Identifies a New Lead Compound

  6/4/2008

• Pharmacopeia, Inc. to Cut Jobs, Sees Charge in Q2

  5/30/2008

• Pharmacopeia, Inc. Shares Rise On Blood Pressure Study; First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients

  5/16/2008

• Pharmacopeia, Inc. Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540

  4/15/2008

• Pharmacopeia, Inc. CEO Resigns

  4/11/2008

• Pharmacopeia, Inc. to Receive $5 Million Payment from GlaxoSmithKline

  3/18/2008